Insider Trading activities of Invitrogen Corp insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Invitrogen Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Invitrogen Corp since year 2005. Table 2 shows the detailed insider transactions of Invitrogen Corp since 2005. The reporting company's ticker symbol is IVGN. The reporting company's CIK number is 1073431.
The total value of stock buying since 2005 is $3,880,122.
The total value of stock sales since 2005 is $196,970,946.
The total value of stock option exercises since 2005 is $159,543,907.


Go to page:  1   2   3 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Invitrogen Corp (IVGN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2013-09 0 $0 0 $0 2,404 $179,290
2013-08 0 $0 0 $0 1,726 $129,070
2013-05 0 $0 62,010 $4,591,610 60,000 $1,831,800
2013-04 0 $0 0 $0 191,475 $12,991,497
2013-03 0 $0 0 $0 158,232 $8,531,130
2013-02 0 $0 0 $0 3,572 $233,037
2012-12 0 $0 20,000 $1,021,240 527,352 $9,945,560
2012-11 0 $0 18,246 $882,502 161,943 $7,970,834
2012-10 0 $0 6,958 $337,602 6,958 $160,034
2012-09 0 $0 169,868 $8,493,400 3,828 $184,547
2012-05 0 $0 20,000 $934,300 20,000 $351,200
2012-04 3,330 $154,815 0 $0 116,484 $5,593,101
2012-03 0 $0 500 $23,189 2,174 $104,743
2012-02 0 $0 500 $23,827 0 $0
2012-01 0 $0 20,000 $1,013,000 20,000 $351,200
2011-11 0 $0 2,474 $90,894 136,076 $4,993,987
2011-10 0 $0 0 $0 4,052 $150,774
2011-08 15,550 $620,887 0 $0 13,232 $431,724
2011-06 0 $0 1,000 $51,040 1,000 $31,860
2011-05 200 $11,048 4,000 $221,752 14,720 $817,994
2011-04 0 $0 0 $0 23,439 $1,311,645
2011-03 0 $0 33,342 $1,684,937 33,342 $943,351
2011-02 0 $0 500 $26,863 0 $0
2011-01 0 $0 43,411 $2,447,817 43,411 $1,387,151
2010-12 0 $0 229,973 $12,318,266 232,509 $5,835,491
2010-11 0 $0 100,197 $5,077,376 23,000 $711,050
2010-10 0 $0 100,000 $5,030,500 0 $0
2010-09 0 $0 20,000 $929,920 20,000 $666,200
2010-08 0 $0 1,000 $43,952 1,000 $31,860
2010-06 0 $0 14,100 $708,829 41,700 $1,846,568
2010-05 0 $0 19,298 $997,781 50,500 $2,214,353
2010-04 0 $0 14,781 $812,955 14,500 $477,629
2010-03 0 $0 131,218 $6,884,480 134,251 $5,084,824
2010-02 0 $0 20,974 $1,034,488 586,556 $29,207,219
2010-01 0 $0 0 $0 6,000 $313,320
2009-12 0 $0 117,998 $6,096,792 81,444 $2,602,739
2009-11 0 $0 126,351 $6,343,801 89,713 $2,609,130
2009-09 0 $0 266,093 $12,599,802 266,611 $7,456,807
2009-07 0 $0 24,500 $1,079,500 24,500 $705,480
2009-06 0 $0 26,767 $1,070,380 0 $0
2009-05 10,700 $388,378 12,050 $441,093 39,200 $0
2009-04 0 $0 7,084 $252,721 0 $0
2009-03 600 $16,807 1,166 $34,268 22,014 $0
2009-02 0 $0 5,455 $162,128 0 $0
2009-01 0 $0 0 $0 5,218 $127,632
2008-12 0 $0 0 $0 30,000 $0
2008-11 77,800 $2,002,160 0 $0 71,200 $0
2008-07 0 $0 0 $0 40,000 $0
2008-06 0 $0 0 $0 1,200 $43,416
2008-05 0 $0 17,775 $1,653,670 38,950 $1,322,536
2008-04 0 $0 9,450 $865,818 8,883 $0
2008-03 0 $0 2,500 $214,050 2,500 $0
2008-02 0 $0 29,771 $2,603,075 42,096 $2,176,910
2008-01 0 $0 5,875 $541,675 5,875 $332,466
2007-12 0 $0 482,877 $46,702,550 302,487 $14,296,742
2007-11 0 $0 66,587 $6,129,922 88,804 $4,803,925
2007-10 0 $0 432,104 $37,699,619 292,000 $10,338,144
2007-09 0 $0 39,313 $3,145,040 25,421 $560,815
2007-08 0 $0 23,587 $1,848,617 400 $28,944
2007-07 0 $0 7,250 $543,750 2,000 $7,600
2007-06 0 $0 23,822 $1,766,539 17,550 $696,650
2007-05 0 $0 1,617 $116,173 16,500 $0
2007-02 0 $0 105,035 $6,949,494 109,135 $6,299,928
2006-08 4,108 $234,269 0 $0 0 $0
2006-06 100 $6,326 0 $0 0 $0
2006-05 3,000 $192,379 394 $26,417 0 $0
2006-03 0 $0 5,000 $348,630 0 $0
2005-11 1,530 $99,485 0 $0 0 $0
2005-08 0 $0 262 $22,382 0 $0
2005-05 0 $0 25,613 $2,030,520 10,000 $120,000
2005-03 1,000 $71,080 0 $0 0 $0
2005-02 1,200 $82,488 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Invitrogen Corp insiders (IVGN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-09-03 Leddy Peter Michael (SVP, Global Human Resources) Option Ex 2,404 74.58 179,290
2013-08-01 Richard Kelli (Chief Accounting Officer) Option Ex 1,726 74.78 129,070
2013-05-29 Uprichard David C (Director) Sale 2,010 74.04 148,820
2013-05-28 Cottingham John A (Chief Legal Officer) Sale 30,000 74.23 2,226,840
2013-05-28 Cottingham John A (Chief Legal Officer) Option Ex 30,000 30.53 915,900
2013-05-24 Cottingham John A (Chief Legal Officer) Sale 30,000 73.86 2,215,950
2013-05-24 Cottingham John A (Chief Legal Officer) Option Ex 30,000 30.53 915,900
2013-04-29 Iyer Balakrishnan S (Director) Option Ex 4,888 73.68 360,147
2013-04-26 Uprichard David C (Director) Option Ex 4,888 73.74 360,441
2013-04-25 Lorimier Bradley G (Director) Option Ex 31,964 73.70 2,355,746
2013-04-25 Levine Arnold J (Director) Option Ex 19,432 73.70 1,432,138
2013-04-24 Levine Arnold J (Director) Option Ex 1,222 73.70 90,061
2013-04-02 Stevenson Mark (President & COO) Option Ex 10,479 65.75 688,994
2013-04-02 Leddy Peter Michael (SVP, Global Human Resources) Option Ex 3,067 65.75 201,655
2013-04-02 Hoffmeister David F (Chief Financial Officer) Option Ex 5,112 65.75 336,114
2013-04-02 Andrews Ronald Asbury (President, Medical Sciences) Option Ex 3,067 65.75 201,655
2013-04-02 Richard Kelli (Chief Accounting Officer) Option Ex 1,534 65.75 100,860
2013-04-02 Lucier Gregory T (Chief Executive Officer) Option Ex 23,002 65.75 1,512,381
2013-04-02 Cottingham John A (Chief Legal Officer) Option Ex 3,067 65.75 201,655
2013-04-01 Stevenson Mark (President & COO) Option Ex 18,765 64.57 1,211,656
2013-04-01 Leddy Peter Michael (SVP, Global Human Resources) Option Ex 5,630 64.57 363,529
2013-04-01 Hoffmeister David F (Chief Financial Officer) Option Ex 9,383 64.57 605,860
2013-04-01 Richard Kelli (Chief Accounting Officer) Option Ex 2,815 64.57 181,764
2013-04-01 Lucier Gregory T (Chief Executive Officer) Option Ex 37,530 64.57 2,423,312
2013-04-01 Cottingham John A (Chief Legal Officer) Option Ex 5,630 64.57 363,529
2013-03-08 Dittamore Raymond V (Director) Option Ex 20,000 15.04 300,800
2013-03-01 Stevenson Mark (President & COO) Option Ex 24,509 59.54 1,459,265
2013-03-01 Leddy Peter Michael (SVP, Global Human Resources) Option Ex 11,764 59.54 700,428
2013-03-01 Hoffmeister David F (Chief Financial Officer) Option Ex 19,607 59.54 1,167,400
2013-03-01 Richard Kelli (Chief Accounting Officer) Option Ex 5,882 59.54 350,214
2013-03-01 Lucier Gregory T (Chief Executive Officer) Option Ex 70,588 59.54 4,202,809
2013-03-01 Cottingham John A (Chief Legal Officer) Option Ex 5,882 59.54 350,214
2013-02-01 Andrews Ronald Asbury (President, Medical Sciences) Option Ex 3,572 65.24 233,037
2012-12-27 Lucier Gregory T (Chief Executive Officer) Option Ex 150,655 19.01 2,863,951
2012-12-26 Lucier Gregory T (Chief Executive Officer) Option Ex 356,697 19.01 6,780,809
2012-12-11 Lorimier Bradley G (Director) Sale 20,000 51.06 1,021,240
2012-12-11 Lorimier Bradley G (Director) Option Ex 20,000 15.04 300,800
2012-11-21 Lucier Gregory T (Chief Executive Officer) Option Ex 161,943 49.22 7,970,834
2012-11-20 Grimm Donald W (Director) Sale 8,000 47.98 383,840
2012-11-19 Grimm Donald W (Director) Sale 4,052 47.86 193,912
2012-11-06 Richard Kelli (Chief Accounting Officer) Sale 6,194 49.20 304,750
2012-10-15 Levine Arnold J (Director) Sale 6,958 48.52 337,602
2012-10-15 Levine Arnold J (Director) Option Ex 6,958 23.00 160,034
2012-09-18 Lucier Gregory T (Chief Executive Officer) Sale 169,868 50.00 8,493,400
2012-09-04 Leddy Peter Michael (SVP, Global Human Resources) Option Ex 2,404 48.21 115,896
2012-09-04 Richard Kelli (Chief Accounting Officer) Option Ex 1,424 48.21 68,651
2012-05-01 Lorimier Bradley G (Director) Sale 20,000 46.72 934,300
2012-05-01 Lorimier Bradley G (Director) Option Ex 20,000 17.56 351,200
2012-04-30 Dittamore Raymond V (Director) Option Ex 4,021 46.36 186,413
2012-04-27 Andrews Ronald Asbury (President, Medical Sciences) Buy 3,330 46.49 154,815
2012-04-26 Longfield William H (Director) Option Ex 32,709 46.04 1,505,922
2012-04-02 Stevenson Mark (President & COO) Option Ex 18,765 48.91 917,796
2012-04-02 Leddy Peter Michael (SVP, Global Human Resources) Option Ex 5,630 48.91 275,363
2012-04-02 Hoffmeister David F (Chief Financial Officer) Option Ex 9,383 48.91 458,922
2012-04-02 Richard Kelli (Chief Accounting Officer) Option Ex 2,815 48.91 137,681
2012-04-02 Lucier Gregory T (Chief Executive Officer) Option Ex 37,531 48.91 1,835,641
2012-04-02 Cottingham John A (Chief Legal Officer) Option Ex 5,630 48.91 275,363
2012-03-15 Uprichard David C (Director) Sale 200 46.08 9,216
2012-03-09 Uprichard David C (Director) Sale 100 46.60 4,660
2012-03-08 Uprichard David C (Director) Sale 200 46.56 9,313
2012-03-01 Richard Kelli (Chief Accounting Officer) Option Ex 2,174 48.18 104,743
2012-02-27 Uprichard David C (Director) Sale 500 47.66 23,827
2012-01-25 Dittamore Raymond V (Director) Sale 20,000 50.65 1,013,000
2012-01-25 Dittamore Raymond V (Director) Option Ex 20,000 17.56 351,200
2011-11-22 Leddy Peter Michael (SVP, Global Human Resources) Sale 2,474 36.74 90,894
2011-11-21 Stevenson Mark (President & COO) Option Ex 44,984 36.70 1,650,912
2011-11-21 Leddy Peter Michael (SVP, Global Human Resources) Option Ex 24,741 36.70 907,994
2011-11-21 Hoffmeister David F (Chief Financial Officer) Option Ex 41,610 36.70 1,527,087
2011-11-21 Cottingham John A (Chief Legal Officer) Option Ex 24,741 36.70 907,994
2011-10-03 Grimm Donald W (Director) Option Ex 4,052 37.21 150,774
2011-08-22 Pescovitz Ora H. (Director) Buy 550 36.16 19,887
2011-08-22 Stevenson Mark (President & COO) Buy 5,000 36.20 181,000
2011-08-22 Lucier Gregory T (Chief Executive Officer) Option Ex 12,232 32.69 399,864
2011-08-22 Uprichard David C (Director) Option Ex 400 31.86 12,744
2011-08-11 Uprichard David C (Director) Option Ex 600 31.86 19,116
2011-08-05 Lucier Gregory T (Chief Executive Officer) Buy 10,000 42.00 420,000
2011-06-07 Uprichard David C (Director) Sale 1,000 51.04 51,040
2011-06-07 Uprichard David C (Director) Option Ex 1,000 31.86 31,860
2011-05-16 Leddy Peter Michael (SVP, Global Human Resources) Option Ex 3,414 55.62 189,886
2011-05-16 Hoffmeister David F (Chief Financial Officer) Option Ex 3,200 55.62 177,984
2011-05-16 Richard Kelli (Chief Accounting Officer) Option Ex 1,066 55.62 59,290
2011-05-16 Cottingham John A (Chief Legal Officer) Option Ex 2,988 55.62 166,192
2011-05-03 Uprichard David C (Director) Sale 4,000 55.44 221,752
2011-05-02 Pescovitz Ora H. (Director) Buy 200 55.24 11,048
2011-05-02 Uprichard David C (Director) Option Ex 4,052 55.44 224,642
2011-04-28 Dittamore Raymond V (Director) Option Ex 4,052 55.96 226,749
2011-04-28 Reynolds W Ann (Director) Option Ex 19,387 55.96 1,084,896
2011-03-15 Grossman Paul David (SVP, Corporate Strategy & Dev.) Sale 18,556 50.40 935,129
2011-03-15 Grossman Paul David (SVP, Corporate Strategy & Dev.) Option Ex 18,556 22.23 412,499
2011-03-15 Levine Arnold J (Director) Sale 6,958 50.25 349,618
2011-03-15 Levine Arnold J (Director) Option Ex 6,958 32.17 223,838
2011-03-11 Adam George F Jr (Director) Sale 7,828 51.12 400,190
2011-03-11 Adam George F Jr (Director) Option Ex 7,828 39.22 307,014
2011-02-24 Uprichard David C (Director) Sale 100 52.61 5,261
2011-02-18 Uprichard David C (Director) Sale 100 54.17 5,417
2011-02-15 Uprichard David C (Director) Sale 100 54.32 5,432
2011-02-11 Uprichard David C (Director) Sale 100 53.98 5,398
2011-02-09 Uprichard David C (Director) Sale 100 53.55 5,355
2011-01-03 Brust Bernd (President, Molecular Medicine) Sale 11,750 57.00 669,750
2011-01-03 Brust Bernd (President, Molecular Medicine) Option Ex 11,750 28.30 332,525
2011-01-03 Lorimier Bradley G (Director) Sale 20,000 56.24 1,124,189
2011-01-03 Lorimier Bradley G (Director) Option Ex 20,000 33.31 666,199
2010-12-29 Brust Bernd (President, Molecular Medicine) Sale 6,250 56.00 350,000
2010-12-29 Brust Bernd (President, Molecular Medicine) Option Ex 6,250 27.51 171,937
2010-12-22 Barthelemy Nicolas (Pres, Commercial Operations) Option Ex 3,036 32.94 100,005
2010-12-17 Miller John L (President, Genetic Systems) Sale 31,208 55.41 1,725,119
2010-12-17 Miller John L (President, Genetic Systems) Option Ex 31,208 22.23 693,753
2010-12-15 Uprichard David C (Director) Sale 700 55.00 38,500
2010-12-15 Uprichard David C (Director) Option Ex 500 35.53 17,765
2010-12-14 Uprichard David C (Director) Sale 600 54.54 32,727
2010-12-14 Uprichard David C (Director) Option Ex 500 35.53 17,765
2010-12-13 Richard Kelli (Chief Accounting Officer) Sale 15,291 53.13 812,390
2010-12-13 Richard Kelli (Chief Accounting Officer) Option Ex 15,291 32.06 489,971
2010-12-10 Barthelemy Nicolas (Pres, Commercial Operations) Sale 31,208 52.80 1,647,876
2010-12-10 Barthelemy Nicolas (Pres, Commercial Operations) Option Ex 31,208 22.23 693,753
2010-12-10 Cottingham John A (Chief Legal Officer) Sale 38,400 52.75 2,025,600
2010-12-10 Cottingham John A (Chief Legal Officer) Option Ex 38,400 22.82 876,288
2010-12-10 Iyer Balakrishnan S (Director) Sale 20,000 52.73 1,053,588
2010-12-10 Iyer Balakrishnan S (Director) Option Ex 20,000 30.59 611,800
2010-12-03 Brust Bernd (Pres, Commercial Operations) Sale 31,208 52.99 1,653,711
2010-12-03 Brust Bernd (Pres, Commercial Operations) Option Ex 31,208 22.23 693,753
2010-12-03 Uprichard David C (Director) Sale 1,100 53.12 58,436
2010-12-03 Uprichard David C (Director) Option Ex 1,000 35.53 35,530
2010-12-02 Uprichard David C (Director) Sale 1,100 52.18 57,401
2010-12-02 Uprichard David C (Director) Option Ex 1,000 31.86 31,860
2010-11-24 Uprichard David C (Director) Sale 100 51.43 5,143
2010-11-22 Grossman Paul David (SVP, Corporate Strategy & Dev.) Sale 14,029 50.35 706,388
2010-11-19 Uprichard David C (Director) Sale 100 50.66 5,066
2010-11-17 Uprichard David C (Director) Sale 100 49.74 4,974
2010-11-05 Dittamore Raymond V (Director) Sale 20,000 51.69 1,033,740
2010-11-05 Dittamore Raymond V (Director) Option Ex 20,000 30.59 611,800
2010-11-04 Uprichard David C (Director) Sale 1,000 51.90 51,901
2010-11-04 Uprichard David C (Director) Option Ex 1,000 31.86 31,860
2010-11-03 Uprichard David C (Director) Sale 2,000 50.68 101,366
2010-11-03 Uprichard David C (Director) Option Ex 2,000 33.70 67,390
2010-11-01 Lucier Gregory T (Chief Executive Officer) Sale 62,868 50.40 3,168,798
2010-10-29 Lucier Gregory T (Chief Executive Officer) Sale 100,000 50.30 5,030,500
2010-09-09 Grimm Donald W (Director) Sale 20,000 46.50 929,920
2010-09-09 Grimm Donald W (Director) Option Ex 20,000 33.31 666,200
2010-08-20 Uprichard David C (Director) Sale 1,000 43.95 43,952
2010-08-20 Uprichard David C (Director) Option Ex 1,000 31.86 31,860
2010-06-15 Uprichard David C (Director) Sale 4,700 50.74 238,619
2010-06-15 Uprichard David C (Director) Option Ex 4,000 34.61 138,448
2010-06-14 Dansky Peter (Pres, Molecular Biology Sys) Option Ex 2,700 22.23 60,021
2010-06-14 Uprichard David C (Director) Sale 99 50.60 5,009
2010-06-11 Uprichard David C (Director) Sale 1,001 49.85 49,902
2010-06-11 Uprichard David C (Director) Option Ex 1,000 33.70 33,695
2010-06-10 Uprichard David C (Director) Sale 2,100 49.17 103,259
2010-06-10 Uprichard David C (Director) Option Ex 2,000 34.31 68,614
2010-06-09 Uprichard David C (Director) Sale 1,000 48.05 48,049
Go to page:  1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of IVGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Invitrogen Corp (symbol IVGN, CIK number 1073431) see the Securities and Exchange Commission (SEC) website.